Glucagon-like peptide-1 receptor agonists, also known as GLP-1 agonists, GLP-1 receptor agonists, GLP-1 RAs, incretin mimetics, or GLP-1 analogs, are a class of medications used to treat people with type 2 diabetes mellitus (T2DM) and obesity
Harness the power of GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper), a naturally occurring copper peptide prized for helping improve the appearance of firmer, smoother, and more radiant skin
The critical insight: stopping early often leads to weight regain, while staying consistent produces durable metabolic improvements including better insulin sensitivity and reduced cardiovascular risk markers
Primary Phase 3 readouts from the TRIUMPH program are currently ongoing
Well then create a customized treatment plan targeting your specific trouble spots